CONCORD, NC, Sept. 14, 2023 (GLOBE NEWSWIRE) — Hydromer Inc. (OTC: HYDI) (“The Company”), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today the release of a letter to shareholders from its Executive Chairman, Mr. Braeden Lichti. This letter, which is available for viewing at 2023-002.pdf (hydromer.com), offers an overview of the company’s current state. It elucidates both the achievements and challenges faced by the company, presents key highlights and recent updates, and outlines our strategic vision for the future.
About Hydromer, Inc.
Hydromer® has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 40 years. As a trusted partner to large and small companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. We are an FDA, GMP/ISO 13485, and ISO 9001 production facility located in Concord, North Carolina.
This press release contains forward-looking statements that are based on Hydromer’s current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.